Join us on for a webinar on February 21, 2012 (1-2 pm Central) to learn about the validation study (ECOG E5194) that is leading to a new decision making tool for women diagnosed with DCIS. Our speaker will be Lawrence J. Solin, MD.
To register online:
To register from a mobile device:
Have a question you would like to send to the speaker? Just go to the registration link to pre-submit your question for discussion on the webinar. The webinar will be recorded for later playback. Instructions for joining the online meeting room will be sent following registration..
For more background on DCIS and the 2009 NIH State of the Science Consensus report “Diagnosis and Management of Ductal Carcinoma In Situ (DCIS)” go to: http://consensus.nih.gov/2009/DCIS%20images/dcis_finalstmt.pdf.
About our speaker:
Lawrence J. Solin, MD, FACR, FASTRO, is Chairman of the Department of Radiation Oncology at the Albert Einstein Medical Center in Philadelphia, PA. Dr. Solin has concentrated his research interests on breast conservation treatment with radiation for early stage breast cancer. His recent research has focused on the use of breast conservation treatment with radiation for ductal carcinoma in situ (DCIS), long-term outcomes after breast conservation treatment for invasive breast carcinoma and for DCIS, technical approaches to radiation treatment delivery, and biologically defined subsets of breast cancer. He maintains an active clinical practice in the area of radiation treatment for breast cancer. He has contributed over 170 peer-reviewed publications to the medical literature, has presented more than 160 invited national and international lectures, and serves on nine journal editorial boards. He is a co-editor of the book, Breast Cancer Management and Molecular Medicine: Towards Tailored Approaches. Dr. Solin is Professor Emeritus at the University of Pennsylvania in Philadelphia, PA.
This online event is organized by Research Advocacy Network to increase advocate's understanding of current issues in research. Questions concerning this event should be directed to email@example.com.
The Advocate Grand Rounds Series is supported by an unrestricted educational grant from Genomic Health, Inc.